Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT02191488
What this trial is testing

ALA-induced PpIX Fluorescence During Brain Tumor Resection

Who this might be right for
Brain Tumors
David W. Roberts 540
Testing effectiveness (Phase 2)Study completedNCT00502203
What this trial is testing

Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus

Who this might be right for
Mixed Tumor, Mullerian
M.D. Anderson Cancer Center 23
Early research (Phase 1)Study completedNCT02603003
What this trial is testing

The"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCs

Who this might be right for
Non-small Cell Lung Cancer(NSCLC)
Shanghai University of Traditional Chinese Medicine 218
Testing effectiveness (Phase 2)WithdrawnNCT00478270
What this trial is testing

Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.

Who this might be right for
PainBone NeoplasmNeoplasm Metastasis
Hoffmann-La Roche
Not applicableLooking for participantsNCT06697483
What this trial is testing

Risk Stratification and MRD-driven Maintenance for MM After ASCT

Who this might be right for
Multiple Myeloma
Peking University People's Hospital 100
Early research (Phase 1)UnknownNCT05728541
What this trial is testing

Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
CSPC Ouyi Pharmaceutical Co., Ltd. 367
Early research (Phase 1)Study completedNCT01212341
What this trial is testing

Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor

Who this might be right for
Malignant LymphomasSolid Tumors
Seoul National University Hospital 18
Early research (Phase 1)Active Not RecruitingNCT03025256
What this trial is testing

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Who this might be right for
Acral Lentiginous MelanomaCentral Nervous System MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8+7 more
M.D. Anderson Cancer Center 75
Testing effectiveness (Phase 2)Study completedNCT00309842
What this trial is testing

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Masonic Cancer Center, University of Minnesota 213
Early research (Phase 1)Active Not RecruitingNCT03233854
What this trial is testing

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

Who this might be right for
B Acute Lymphoblastic LeukemiaCD19 PositiveMinimal Residual Disease+1 more
Stanford University 56
Not applicableStudy completedNCT01617954
What this trial is testing

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Who this might be right for
Hormone Receptor Positive Malignant Neoplasm of Breast
Agendia 820
Testing effectiveness (Phase 2)Looking for participantsNCT06732856
What this trial is testing

A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer

Who this might be right for
Stomach NeoplasmGastric (Stomach) Cancer
Asan Medical Center 57
Early research (Phase 1)Not Yet RecruitingNCT06647329
What this trial is testing

CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors

Who this might be right for
CAR-T Cell TherapyLymphomas
Mingzhi Zhang 30
Very early researchUnknownNCT02817945
What this trial is testing

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Who this might be right for
Lung CancerNeuroendocrine Neoplasm
Peking Union Medical College Hospital 100
Early research (Phase 1)Study completedNCT02916095
What this trial is testing

Kanitinib in Treating Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Beijing Konruns Pharmaceutical Co., Ltd. 9
Testing effectiveness (Phase 2)Ended earlyNCT00910039
What this trial is testing

Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases

Who this might be right for
Cognitive/Functional EffectsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07817095
What this trial is testing

SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripalimab as Neoadjuvant Therapy for Localized High-Risk Undifferentiated Pleomorphic Sarcoma

Who this might be right for
Undifferentiated Pleomorphic Sarcoma (UPS)
Tianjin Medical University Cancer Institute and Hospital 39
Testing effectiveness (Phase 2)Temporarily pausedNCT00065572
What this trial is testing

Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)

Who this might be right for
Carcinoma, Renal CellKidney Neoplasms
AstraZeneca
Testing effectiveness (Phase 2)UnknownNCT01565837
What this trial is testing

Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma

Who this might be right for
Melanoma
Wolfram Samlowski 50
Not applicableStudy completedNCT02948751
What this trial is testing

Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast Cancer

Who this might be right for
Breast CancerLeptomeningeal Metastasis
Columbia University 14
Next Page